Lee et al. (2007) showed that the lack of osteocalcin gene resulted in some metabolic dysfunction such as hyperglycemia, glucose intolerance, increasing fat mass and serum triglyceride level, and decreasing β‐cell production, insulin secretion, and adiponectin expression. The gene discussed is INS; the disease is Hyperglycemia.